These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3783906)

  • 61. Familial Hypercholesterolemia: The Most Frequent Cholesterol Metabolism Disorder Caused Disease.
    Benito-Vicente A; Uribe KB; Jebari S; Galicia-Garcia U; Ostolaza H; Martin C
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30388787
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Familial hypercholesterolaemia: A global call to arms.
    Vallejo-Vaz AJ; Kondapally Seshasai SR; Cole D; Hovingh GK; Kastelein JJ; Mata P; Raal FJ; Santos RD; Soran H; Watts GF; Abifadel M; Aguilar-Salinas CA; Akram A; Alnouri F; Alonso R; Al-Rasadi K; Banach M; Bogsrud MP; Bourbon M; Bruckert E; Car J; Corral P; Descamps O; Dieplinger H; Durst R; Freiberger T; Gaspar IM; Genest J; Harada-Shiba M; Jiang L; Kayikcioglu M; Lam CS; Latkovskis G; Laufs U; Liberopoulos E; Nilsson L; Nordestgaard BG; O'Donoghue JM; Sahebkar A; Schunkert H; Shehab A; Stoll M; Su TC; Susekov A; Widén E; Catapano AL; Ray KK
    Atherosclerosis; 2015 Nov; 243(1):257-9. PubMed ID: 26408930
    [No Abstract]   [Full Text] [Related]  

  • 63. Examining barriers to cascade screening for familial hypercholesterolemia in the United States.
    Andersen R; Andersen L
    J Clin Lipidol; 2016; 10(2):225-7. PubMed ID: 27055953
    [No Abstract]   [Full Text] [Related]  

  • 64. [Spectacular presentation of tuberous xanthomas revealing a homozygous familial hypercholesterolemia].
    Rachadi H; Ramli I; Touzani A; Hassam B; Ismaili N
    Presse Med; 2016 Feb; 45(2):269-71. PubMed ID: 26796480
    [No Abstract]   [Full Text] [Related]  

  • 65. Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
    Hopkins PN; Toth PP; Ballantyne CM; Rader DJ;
    J Clin Lipidol; 2011 Jun; 5(3 Suppl):S9-17. PubMed ID: 21600530
    [No Abstract]   [Full Text] [Related]  

  • 66. [Familial hypercholesterolemia. Proposed measures favoring systematic screening].
    Sabourin G
    Perspect Infirm; 2015; 12(3):14. PubMed ID: 26079033
    [No Abstract]   [Full Text] [Related]  

  • 67. Long-Term Cardiovascular Risk in Heterozygous Familial Hypercholesterolemia Relatives Identified by Cascade Screening.
    Kjærgaard KA; Christiansen MK; Schmidt M; Olsen MS; Jensen HK
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28652386
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The Essential Role of Primary Caregiver in Early Detection of Familial Hypercholesterolemia and Cardiovascular Prevention.
    St-Pierre J; Ruel I; Genest J
    Curr Pediatr Rev; 2017; 13(4):260-264. PubMed ID: 29473516
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Attitude of patients toward detection of hereditary disease. Heterozygote familial hypercholesterolemia].
    Andersen LK; Jensen HK; Juul S; Faergeman O
    Ugeskr Laeger; 1998 Oct; 160(42):6075-81. PubMed ID: 9800511
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Familial hypercholesterolemia: A largely underestimated cardiovascular risk].
    Ferrières J; Bruckert É; Béliard S; Rabès JP; Farnier M; Krempf M; Cariou B; Danchin N
    Ann Cardiol Angeiol (Paris); 2018 Feb; 67(1):1-8. PubMed ID: 28576280
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Risk assessment and strategies to achieve lipid goals: lessons from real-world clinical practice.
    Schuster H
    Am J Med; 2004 Mar; 116 Suppl 6A():26S-30S. PubMed ID: 15050189
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Association of seropositivity for Chlamydia pneumoniae and coronary artery disease in heterozygous familial hypercholesterolaemia.
    Kontula K; Vuorio A; Turtola H; Saikku P
    Lancet; 1999 Jul; 354(9172):46-7. PubMed ID: 10406370
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Homozygous familial hypercholesterolemia.
    Diwan AG; Krishna KK; Jain MM; Arafat M; Sardesai VR; Dube MN
    J Assoc Physicians India; 2002 May; 50(5):738-9. PubMed ID: 12186142
    [No Abstract]   [Full Text] [Related]  

  • 74. Defining the challenges of FH screening for familial hypercholesterolemia.
    Defesche JC
    J Clin Lipidol; 2010; 4(5):338-41. PubMed ID: 21122674
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [The problem of familial hypercholesterolemia].
    Pedro-Botet JC; Millán Núñez-Cortes J; Lahera Julia V; Vázquez Carrera M
    Clin Investig Arterioscler; 2013; 25(4):174. PubMed ID: 24183481
    [No Abstract]   [Full Text] [Related]  

  • 76. [Homozygous familial hypercholesterolemia (author's transl)].
    Nervi F; Arteaga A; Maiz A; Tocornal J; Severin MC
    Rev Med Chil; 1979 Jul; 107(7):624-8. PubMed ID: 232560
    [No Abstract]   [Full Text] [Related]  

  • 77. [Familial hypercholesterolemia: why screening, counselling and treatment should be integrated].
    Roeters van Lennep JE; Visseren FL; Jira PE
    Ned Tijdschr Geneeskd; 2015; 159():A8875. PubMed ID: 26013253
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Genotype-guided diagnosis in familial hypercholesterolemia: clinical management and concerns.
    Hopkins PN; Lane SR
    Curr Opin Lipidol; 2017 Apr; 28(2):144-151. PubMed ID: 28157722
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Familial hypercholesterolemia: a treatable lethal disease.
    Davignon J
    Can J Cardiol; 1991; 7(1):VI-VII. PubMed ID: 2025783
    [No Abstract]   [Full Text] [Related]  

  • 80. [Hypercholesterolemia in children and adolescents. Active follow-up needed].
    Tornqvist H; Hernell O; Samuelson G
    Lakartidningen; 1991 Nov; 88(48):4107-9. PubMed ID: 1956245
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.